报价延迟最少15分钟:2025/09/17 03:57 EDT
盘前时段
|
||||
|
-- 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
131.82
|
|
|
| 价值评估 |
|
盈利(现时/预测)
5.92/10.74
|
|
企业价值
9.59B
|
| 资产负债 |
|
每股账面净值
53.98
|
| 现金流量 |
|
现金流量率
0.08
|
| 损益表 |
|
收益
4.00B
|
|
每股收益
52.52
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/09/17 03:57 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans. |
